May provide docking sites for other molecules (e.g. Erk, p130Cas, Crk and Src) or alter molecular confirmation to induce activation; kinase or scaffolding functions in these pathways are likely to contribute to their already well-established role during cancer progression. The gene discussed is CRK; the disease is cancer.